Talis Biomedical Corp. (TLIS) delivers precise infectious disease testing as it is devoted to progressing health equity and outcomes. The company plans the production and
NortonLifeLock Inc. (NLOK) is a global leader in consumer Cyber Safety, protecting and empowering people to live their digital lives safely. We are the consumer’s
FDA Clearance of SON-1010: Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock Moving Forward in Premarket.
Sonnet BioTherapeutics Holdings, Inc. (SONN) is engaged in the development of novel drugs for cancer therapeutics. Its Fully Human Albumin Binding technology utilizes a human single-chain
LexinFintech Holdings Ltd. (LX) is one of the principal e-commerce-based consumption and finance Chinese companies. It connects ever-increasing clients with economic institutions by leveraging a
CarParts.com, Inc. (PRTS) is a leader in providing the best quality car parts at a comparatively reasonable price range. The company markets its products via
TRACON Pharmaceuticals, Inc. (TCON) is a leading late-clinical company focused on the development and marketing of cancer therapeutics along with treatment for macular degeneration and
XpresSpa Group, Inc. (XSPA) is an international leader in providing health and wellness services having three distinct brands: XpresCheck, XpresSpa, and Treat. The services provided
Enveric Biosciences, Inc. (ENVB) is a novel biotherapeutics company engaged in the development of mental illness and cancer therapeutics including cannabinoid compounds. The pipeline projects
General Meeting of Shareholders: Ucommune International Ltd. (UK) Stock Made a Comeback in current market
Ucommune International Ltd. (UK) is a leader in agile office space management and supply. It provides its members with supple and cost-effective office space platforms.
Participation at Healthcare Conference: DBV Technologies S.A. (DBVT) Stock Recovered in Tuesday’s Premarket.
DBV Technologies S.A. (DBVT) is producing an exclusive technology platform known as Viaskin, having a wide range of applications in immunotherapeutics and based on EPIT.